Medifast Inc.

NYSE: MED · Real-Time Price · USD
13.16
0.13 (1.00%)
At close: Aug 15, 2025, 9:57 AM

Medifast Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
480.45M 543.45M 602.46M 674.48M 770.18M 897.81M 1.07B 1.22B 1.37B 1.53B 1.6B 1.64B 1.66B 1.6B 1.53B 1.41B 1.27B 1.1B
Cost of Revenue
125.67M 141.88M 157.84M 176.7M 200.71M 241.06M 296.2M 350.21M 399.26M 445.44M 458.16M 454.06M 452.85M 421.68M 398.49M 364.62M 325.71M 285.93M
Gross Profit
354.78M 401.58M 444.62M 497.77M 569.48M 656.75M 775.85M 868.08M 973.55M 1.08B 1.14B 1.19B 1.21B 1.18B 1.13B 1.05B 945.53M 811.12M
Operating Income
487K -6.32M 2.88M 10.85M 34.25M 80.83M 126.4M 150.32M 172.97M 183.23M 184.81M 199.04M 206.06M 218.53M 216.24M 207.37M 196.76M 163.43M
Interest Income
4.96M 4.88M 3.58M 3.81M 3.5M 2.67M 2.67M 1.68M 644K 182K 182K n/a n/a n/a 23K 57K 101K 159K
Pretax Income
6.25M -7.27M 3.79M 12.31M 37.29M 87.05M 128.8M 151.4M 172.73M 182.41M 184.06M 198.4M 205.72M 218.26M 216.13M 207.23M 196.67M 163.48M
Net Income
3.64M -7M 2.09M 7.33M 29.33M 67.76M 99.41M 119.9M 132.92M 141.75M 143.57M 151.07M 156.9M 164.75M 164.03M 158M 150.47M 125.44M
Selling & General & Admin
350.89M 403.4M 437.24M 483.73M 533.13M 574.92M 649.45M 717.75M 800.58M 901.29M 955.61M 986.06M 1B 962.81M 911.36M 841.18M 748.77M 647.7M
Research & Development
n/a 1.1M 2.1M 3.3M 4.6M 4.6M 4.6M 4.6M 4.4M 4.5M 4.4M 4.3M 4.4M 4.3M 4.4M 4.2M 3.8M 3.2M
Other Expenses
n/a n/a n/a -50K -43K -94K -95K -54K -78K -31K -46K -30K 102K 84K 119K -39K -124K -101K
Operating Expenses
354.3M 407.9M 441.74M 486.93M 535.23M 575.92M 649.45M 717.75M 800.58M 901.29M 955.61M 986.06M 1B 962.81M 911.36M 841.18M 748.77M 647.7M
Interest Expense
n/a n/a 1.22M 1.22M 1.22M 1.22M 181K 362K 623K 787K 701K 613K 446K 349K 254K 161K 67K n/a
Selling & Marketing Expenses
n/a n/a n/a 3.4M 3.4M 3.4M 3.4M 1.7M 1.7M 1.7M 1.7M 1.6M 1.6M 1.6M 1.6M 4.4M 4.4M 4.4M
Cost & Expenses
479.96M 549.77M 599.58M 663.63M 735.93M 816.98M 945.65M 1.07B 1.2B 1.35B 1.41B 1.44B 1.46B 1.38B 1.31B 1.21B 1.07B 933.63M
Income Tax Expense
2.62M -275K 1.7M 4.99M 7.96M 19.29M 29.38M 31.51M 39.81M 40.66M 40.49M 47.33M 48.82M 53.52M 52.1M 49.23M 46.2M 38.04M
Shares Outstanding (Basic)
10.99M 10.95M 10.93M 10.94M 10.94M 10.91M 10.89M 10.89M 10.89M 10.86M 10.91M 10.96M 11.35M 11.56M 11.69M 11.69M 11.75M 11.77M
Shares Outstanding (Diluted)
11.06M 10.95M 10.96M 10.97M 10.94M 10.96M 10.94M 10.93M 10.92M 10.9M 10.99M 11.04M 11.44M 11.64M 11.79M 11.79M 11.86M 11.88M
EPS (Basic)
0.33 -0.65 0.18 0.66 2.68 6.21 9.13 11.01 12.19 12.85 12.79 13.27 13.56 14.12 13.99 13.46 12.80 10.66
EPS (Diluted)
0.32 -0.65 0.18 0.66 2.68 6.20 9.11 10.97 12.12 12.77 12.69 13.17 13.46 14.00 13.87 13.34 12.69 10.59
EBITDA
14.19M 6.4M 12.32M 20.46M 44.08M 90.96M 139.51M 164.38M 183.62M 193.23M 194.26M 207.25M 217.01M 229.36M 224.64M 214.74M 203.15M 169.04M
EBIT
487K -6.32M 6.52M 15.62M 40.06M 87.05M 128.98M 151.76M 173.35M 183.2M 184.76M 199.01M 206.16M 218.61M 216.38M 207.51M 196.85M 163.6M
Depreciation & Amortization
13.7M 12.73M 13.81M 15.06M 16.29M 17.74M 17.71M 17.6M 17.55M 15.77M 13.87M 14.16M 12.42M 12.31M 11.88M 9.29M 8.43M 7.62M